| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $4.8M | -64.0% |
| SG&A Expense | $4.4M | -12.1% |
| Operating Income | -$9.2M | +49.8% |
| Pre-tax Income | -$8.4M | +52.3% |
| Income Tax | $800 | +0.0% |
| Net Income | -$8.4M | +52.3% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | -23.8% |
| Accounts Receivable | $627K | -50.1% |
| Current Assets | $6.4M | -29.2% |
| Total Assets | $8.9M | -23.2% |
| Current Liabilities | $1.8M | -14.9% |
| Total Liabilities | $1.8M | -15.7% |
| Stockholders' Equity | $7.0M | -24.9% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | +46.0% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $4.8M | -58.5% |
| Free Cash Flow | -$6.6M | +46.0% |